U.S. Hospitality Stock News

Warby Parker FY 2025 results: profitability holds on a trailing basis as Q4 swings back to a loss Warby Parker (WRBY) closed FY 2025 with Q4 revenue of US$212 million and a basic EPS loss of US$0.05, while on a trailing twelve month view the business remained just in the black with basic EPS of US$0.01 on US$871.9 million of revenue. Over the last six reported quarters, quarterly revenue has moved from US$190.6 million in Q4 2024 to a range between US$211.9 million and US$223.8 million...

Robert Mauch, President & CEO of Cencora (NYSE:COR), has recently sold a significant number of company shares. These transactions come with no corresponding insider purchases disclosed from the executive. The concentration of insider selling at the top level is drawing fresh attention to management sentiment toward Cencora. Cencora operates in pharmaceutical distribution and related healthcare services, and sits at the center of drug supply chains for manufacturers, pharmacies and...

Universal Health Realty Income Trust (UHT) has just wrapped up FY 2025 with Q4 revenue of US$23.3 million and basic EPS of US$0.31, alongside Funds From Operations of a loss of US$35.9 million that will likely catch investors’ attention. The trust has seen quarterly revenue move from US$24.8 million in Q3 2024 to between US$24.0 million and US$25.7 million through 2025, while basic EPS ranged from US$0.29 to US$0.35 across those same quarters. This sets up a picture where headline...

Paramount Skydance (PSKY) FY 2025 earnings snapshot Paramount Skydance (PSKY) has wrapped up FY 2025 with Q4 revenue of about US$8.1 billion and a basic EPS loss of US$0.52, as full year trailing twelve month figures show revenue of roughly US$28.9 billion alongside a basic EPS loss of US$0.55. Over recent quarters, revenue has moved from US$6.7 billion in Q3 2024 to US$8.1 billion in Q4 2025. Quarterly EPS has ranged from a profit of US$0.23 in Q1 2025 to losses of US$0.28 and US$0.52 in Q3...

Option Care Health reported strong 2025 results, with significant revenue growth and expanded service offerings across its infusion network. The company increased its footprint of infusion suites and invested in automation and AI to support operational efficiency. Management highlighted disciplined capital allocation, including targeted M&A, while managing headwinds from biosimilar conversions and reimbursement pressures. Option Care Health (NasdaqGS:OPCH) is coming off a year of solid...

In February 2026, Otis Worldwide introduced its Arise MOD Prime and Arise MOD Plus elevator modernization packages in North America, targeting low- to mid-rise residential and commercial buildings with flexible, phased upgrade options. The new Arise MOD offerings combine safety, energy efficiency, and IoT-based monitoring, giving building owners more control over modernization scope, timing, and cost while addressing issues tied to aging elevator infrastructure. We’ll now examine how this...

Digi International recently launched its Model Context Protocol (MCP) server for Digi Remote Manager and Genesis, enabling secure integration of large language model assistants to automate workflows, query device fleets, and optimize wireless WAN and connected infrastructure management. This move extends Digi’s focus on secure, intelligent connectivity by pairing its SOC 2 Type 2–compliant management platforms with enterprise-grade AI, aiming to make distributed edge deployments more...

If you are wondering whether V.F at around US$19.68 is a bargain or a value trap, you are not alone. This article will walk through what the current price might be saying about the company. The stock has had a mixed run, with a 7 day return of a 5.4% decline and a 30 day return of a 3.0% decline. Year to date it is up 8.4%, but it still shows an 18.1% decline over 1 year and a 70.0% decline over 5 years. Recent news coverage around V.F has focused on its brand portfolio, debt load, and...

Latest FY 2025 Earnings Snapshot Global Net Lease (GNL) has just wrapped up FY 2025 with fourth quarter revenue of US$116.9 million and basic EPS of US$0.20, while funds from operations came in at a loss of US$52.3 million, setting a mixed tone for income focused REIT investors watching the headline numbers. Over recent quarters the company has seen revenue move from US$199.1 million in Q4 2024 to US$132.4 million in Q1 2025, US$124.9 million in Q2 2025, US$121.0 million in Q3 2025 and...

Entrada Therapeutics (TRDA) closed out FY 2025 with Q4 revenue of US$1.3 million and a basic EPS loss of US$0.94, while trailing twelve month figures showed revenue of US$25.4 million and a basic EPS loss of US$3.47. Over the past few quarters, the company has seen quarterly revenue move from US$37.4 million in Q4 2024 to US$20.6 million in Q1 2025, then to US$1.9 million, US$1.6 million and US$1.3 million in Q2, Q3 and Q4 2025. Basic EPS shifted from a profit of US$0.03 in Q4 2024 to losses...

Kennedy-Wilson Holdings (KW) has capped FY 2025 with fourth quarter revenue of US$120.6 million and basic EPS of US$0.21, alongside trailing twelve month revenue of US$501 million and a trailing EPS loss of US$0.28. Over recent quarters the company has seen revenue move from US$141.4 million in Q4 2024 to US$130.8 million in Q1 2025, US$142.6 million in Q2 2025, US$135.7 million in Q3 2025 and US$120.6 million in Q4 2025. EPS has ranged from a Q4 2024 level of US$0.24 to quarterly losses...

If you are wondering whether Halliburton is still good value at around US$35.71 per share, you are not alone; many investors are asking the same question as the stock keeps attracting attention. Halliburton shares have returned 1.0% over the last 7 days, 4.2% over the past month, 20.6% year to date and 40.9% over the past year, while the 3 year return sits at a 0.9% decline and the 5 year return at 76.6%. Recent news coverage has focused on Halliburton's role as a large oilfield services...

Baidu (NasdaqGS:BIDU) has wrapped up FY 2025 with fourth quarter revenue of C¥32.7b and basic EPS of C¥5.24, capping a year in which trailing twelve month revenue came in at C¥129.1b and basic EPS at C¥16.40. Over recent quarters the company has seen quarterly revenue move between C¥32.5b and C¥32.7b, while basic EPS has ranged from a loss of C¥33.12 in Q3 2025 to C¥22.44 in Q1 2025. This has occurred alongside a trailing net profit margin of 6.4% compared with 15.3% a year earlier, which...

Mobileye Global (MBLY) is back in focus after pairing its Level 4 Mobileye Drive platform with Elektrobit’s safety-compliant Linux system and outlining plans to apply its artificial community intelligence to humanoid robotics. See our latest analysis for Mobileye Global. These product updates come after a tough stretch for the stock, with the 90 day share price return of 25.97% and a 1 year total shareholder return of 45.82% pointing to fading momentum despite the latest headlines. If this...

Alector (ALEC) has laid out its FY 2025 story with fourth quarter revenue of US$6.2 million, a basic EPS loss of US$0.34 and net income loss of US$37.3 million, set against trailing 12 month revenue of US$21.0 million and a full year EPS loss of US$1.39 on a US$142.9 million net loss. Over recent quarters, the company has seen revenue move between US$3.3 million and US$7.9 million with basic EPS losses ranging from US$0.30 to US$0.41 per quarter, while the prior year fourth quarter showed...

RxSight (RXST) has just reported its FY 2025 numbers with Q4 revenue of US$32.6 million and a basic EPS loss of US$0.22, while on a trailing twelve month basis revenue was US$134.5 million and basic EPS was a loss of US$0.95, keeping the focus firmly on how quickly the business can scale toward profitability. Over the past few quarters, the company has seen revenue range from US$30.3 million to US$40.2 million and basic EPS losses move between US$0.15 and US$0.29, which puts a spotlight on...

American Woodmark (AMWD) has put a tough quarter on the table, with Q3 2026 revenue of US$324.3 million and a basic EPS loss of US$1.97, compared with basic EPS of US$1.10 in Q3 2025. Over the last six reported quarters, revenue has shifted from US$452.5 million in Q2 2025 to US$324.3 million in Q3 2026, while quarterly EPS moved from US$1.81 to a loss of US$1.97 across the same span. This sets up a very different earnings picture to what holders saw a year ago. With trailing 12 month net...

HCI Group (HCI) has capped FY 2025 with fourth quarter revenue of US$246.2 million and basic EPS of US$7.50, rounding out a year where trailing twelve month revenue reached US$900.9 million and EPS came in at US$24.58. Over the past few quarters, the company has seen revenue move from US$161.9 million and EPS of roughly US$0.22 in Q4 2024 to US$216.4 million and EPS of US$6.47 in Q1 2025, US$221.9 million and EPS of US$6.08 in Q2, and US$216.4 million with EPS of about US$5.06 in Q3. This...

Arhaus FY 2025 results set the tone for the next chapter Arhaus (ARHS) has wrapped up FY 2025 with fourth quarter revenue of US$364.8 million and basic EPS of US$0.11, while net income excluding extra items came in at US$15.1 million. The company has seen quarterly revenue move from US$347.0 million in Q4 2024 to US$364.8 million in Q4 2025, with basic EPS shifting from US$0.15 to US$0.11 over the same period. With trailing twelve month net income of US$67.3 million and margins that have...

QXO (QXO) has just reported its FY 2025 numbers, with Q4 revenue of US$2.2 billion and a basic EPS loss of US$0.13 per share on net income excluding extra items of a US$90.2 million loss. Over recent quarters the company has seen revenue move from US$13.5 million and EPS of US$0.03 loss in Q1 2025 to US$2.7 billion and EPS of US$0.24 loss in Q3 2025, before landing at US$2.2 billion and EPS of US$0.13 loss in Q4. Trailing twelve month revenue sits at US$6.8 billion and EPS at US$0.46 loss,...

Analyst enthusiasm meets regulatory clarity for Cigna Group (CI) Recent positive analyst views on Cigna Group (CI) have been shaped by its fourth quarter update, a refocus of its business mix, and fresh regulatory clarity following a broad Federal Trade Commission settlement. See our latest analysis for Cigna Group. At a share price of $288.82, Cigna’s recent 30-day share price return of 6.93% and 90-day share price return of 4.16% suggest momentum has picked up following its fourth quarter...

Carlsmed (CARL) has reported its FY 2025 fourth quarter with total revenue of US$15.2 million and a basic EPS loss of US$0.32, while on a trailing twelve month basis revenue was US$50.5 million and basic EPS was a loss of US$2.12. The company has seen quarterly revenue move from US$9.4 million in Q4 2024 to US$15.2 million in Q4 2025, as basic EPS shifted from a loss of US$1.14 to a loss of US$0.32 over the same period, setting up a story where faster top line expansion is still being weighed...

Chiron Real Estate (XRN) closed out FY 2025 with Q4 total revenue of US$38.4 million and basic EPS of a US$0.55 loss, while over the last 12 months revenue came in at US$148.2 million with EPS of a US$0.91 loss and revenue growth of 2.6% per year. Over recent periods, the company has seen quarterly revenue move from US$35.1 million in Q4 2024 to US$38.4 million in Q4 2025, while basic EPS shifted from US$0.10 to a loss of US$0.55. This sets up a mixed picture, where modest top line progress...

Spok Holdings (SPOK) has wrapped up FY 2025 with fourth quarter revenue of US$33.9 million and basic EPS of US$0.14, while trailing 12 month revenue sits at US$139.7 million and EPS at US$0.77. Over the past six quarters, the company has seen quarterly revenue move in a tight band between US$33.9 million and US$36.3 million. Basic EPS has ranged from US$0.14 to US$0.25, and trailing 12 month EPS has edged from US$0.73 to US$0.81 before landing at US$0.77 most recently. With net profit margins...